MEIP NASDAQ

MEI Pharma, Inc. - Common Stock

Healthcare · Biotechnology
$1.12
▼ $-0.01 (-0.89%)
Vol 219K
8
Quality Score
fail
Mkt Cap
$30.3M
ROE
-127.2%
Margin
39.1%
D/E
0.00
Beta
0.33
52W
$1–$9

Price Chart

Fundamentals Trend

Metric 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31 2025-09-02
ROE (TTM) 48.3% 31.6% -110.7% -116.7% -127.2% -127.2%
P/E (TTM) 0.99 1.07 — — — —
Net Margin — 27.2% — — — 39.0%
Gross Margin — — — — — 100.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 6.17 4.88 9.66 10.66 16.78 16.78

Key Ratios

ROA (TTM)
-110.8%
P/S (TTM)
0.29
P/B
0.6
EPS (TTM)
$-4.75
CF/Share
$6.23
Rev Growth 3Y
+23.3%
52W High
$9.00
52W Low
$1.46
$1.46 52-Week Range $9.00

How does MEIP compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MEIP AAPG ABEO ABOS ABP

MEIP valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.3
▼ 98% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.6
▼ 77% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MEIP profitability vs Biotechnology peers

ROE
-127.2%
▼ 89% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
39.1%
▲ 114% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
100.0%
▲ 27% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-110.8%
▼ 137% below peers (-46.7%)
vs Peers
vs Industry
Weak

MEIP financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
16.8
▲ 278% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼ 66% below peers (1.0)
vs Peers
vs Industry
More volatile

MEIP fundamentals radar

MEIP Peer median Industry

MEIP profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MEIP vs peers: key metrics

Latest News

No related news yet